Pharmaceuticals

Drug Development Drug Pricing Drug Approval Clinical Trials Drug Safety Weight Loss Drugs Biotechnology Prescription Drugs Prescription Medications Drug Regulation

Wall Street Unanimously Bullish on Teva as Austedo Fuels Turnaround

Analysts say rising Austedo sales alongside Teva's move into branded drugs could lift the stock if the company sustains execution.

Stories older than 24h

Virginia Judge Orders FDA to Reconsider 2023 Abortion‑Pill Restrictions

Sanofi Confirms Intermittent U.S. Supply of Lantus SoloStar Pens

NovoCure Posts Record Q2 Revenue and Raises 2026 Outlook

Dassault Systèmes Agrees to Buy ArisGlobal From Nordic Capital

argenx Posts $1.52 Billion Quarter as VYVGART Readouts Loom

Study Finds GLP‑1 Drugs Cut Long‑Term Sick Leave by About 17%

IYH vs PJP: Diversified, Lower‑Cost Healthcare Fund Faces Concentrated Pharma Challenger

Glenmark Settles for $29.6 Million Over Alleged Generic Drug Price Conspiracy

UCL Review Finds GLP‑1 Drugs Reduce Binge Eating Symptoms

Sinopia’s SB-0110 Boosts Levodopa Benefit and Cuts Dyskinesia in Animal Models

Senators Propose Law Requiring Tougher Oversight of Foreign Investment in U.S. Drug Industry

Southern Germany Braces for Another Heatwave as Temperatures Rise Above 30°C

Johnson & Johnson Beats Q2 Estimates and Lifts Full‑Year Outlook

FTC and CVS Caremark Settle, Forcing Rebate Reforms and TrumpRx Deductible Counting

HSE Refers Skyclarys Reimbursement to Rare Diseases Review Committee

HRSA Says 340B Covered Entities Bought $100 Billion in Outpatient Drugs in 2025

How to Choose Between Broad Healthcare ETFs and Biotech-Focused Funds

Late‑Stage Trial of Wainua Misses Primary Goal in ATTR‑CM Study

Vertex to Acquire Crinetics for About $10 Billion